Premium
The development of China's medical biotech industry needs to be driven by innovation
Author(s) -
Yu Zailin,
Dai Yuehan
Publication year - 2006
Publication title -
biotechnology journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.144
H-Index - 84
eISSN - 1860-7314
pISSN - 1860-6768
DOI - 10.1002/biot.200600086
Subject(s) - china , microbiology and biotechnology , chinese market , business , population , economic growth , political science , economics , biology , medicine , environmental health , law
The Chinese biotech industry is going through a period of fast growth, and with its huge population, China is predicted to be the biggest single‐country market in the world. However, the Chinese biotech industry has to tackle the critical issue of innovation, which should be the driving force for China's development into an advanced and responsible country. Here, in this article, the authors review the history of the Chinese biotech industry, exemplified by the development of genetically engineered drugs during the last 20 years, and also point out its the future.